Clinical and economic impact of infusion reactions in patients with colorectal cancer treated with cetuximab.
about
The relevance of tick bites to the production of IgE antibodies to the mammalian oligosaccharide galactose-α-1,3-galactoseA systematic review of observational studies evaluating costs of adverse drug reactionsSystematic review on infusion reactions associated with chemotherapies and monoclonal antibodies for metastatic colorectal cancer.Risk factors for and pre-medications to prevent cetuximab-induced infusion reactions in patients with squamous cell carcinoma of the head and neckIgE and chemotherapy.Cetuximab in non-melanoma skin cancer.Cetuximab hypersensitivity infusion reactions: Incidence and risk factors.Incidence of cetuximab-related infusion reactions in oncology patients treated at the University of North Carolina Cancer Hospital.Successful rechallenge of cetuximab following severe infusion-related reactions: a case reportThe impact of infusion reactions associated with monoclonal antibodies in metastatic colorectal cancer: a European perspective.Utility of serum anti-cetuximab immunoglobulin E levels to identify patients at a high risk of severe hypersensitivity reaction to cetuximab.Infusion reactions to the chimeric EGFR inhibitor cetuximab--change to the fully human anti-EGFR monoclonal antibody panitumumab is safe.Impact of drug substitution on cost of care: an example of economic analysis of cetuximab versus panitumumab
P2860
Q24604244-38C6D432-88E7-4901-9EF1-5AED7B9E7A88Q28079380-DFF4C57B-0690-4B1C-ACD3-4B24A158747DQ31048123-29918D93-ACED-40A3-8F6D-26D83B9EBB5BQ34036360-AE5D19DD-5ED7-40DE-9FF3-01D76D86F1EFQ37964492-FE51C3E4-D3EB-4543-B55E-CE937F811652Q38004033-EF5537DF-C17C-48D4-94C8-16A091730367Q38058453-A84C9B94-13DD-4FA7-8360-9A7FE15BB70AQ38163520-23C76F52-AF4D-4975-B881-CB8918C3FE1AQ41851696-FC3ACEA7-7D13-45D1-8018-F531526EDF59Q46980850-803D8157-6E56-4F97-87CD-569551B5C4C6Q51469542-2F428956-374A-470F-BA99-8D90943446C3Q54619829-4B820F28-8E87-4513-B912-746F153713A0Q59127533-085B9827-BB36-4BB1-8AB2-1E5E8F1F1C88
P2860
Clinical and economic impact of infusion reactions in patients with colorectal cancer treated with cetuximab.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Clinical and economic impact o ...... cancer treated with cetuximab.
@ast
Clinical and economic impact o ...... cancer treated with cetuximab.
@en
type
label
Clinical and economic impact o ...... cancer treated with cetuximab.
@ast
Clinical and economic impact o ...... cancer treated with cetuximab.
@en
prefLabel
Clinical and economic impact o ...... cancer treated with cetuximab.
@ast
Clinical and economic impact o ...... cancer treated with cetuximab.
@en
P2093
P2860
P356
P1433
P1476
Clinical and economic impact o ...... cancer treated with cetuximab.
@en
P2093
B L Barber
J E Bagalman
P2860
P304
P356
10.1093/ANNONC/MDP535
P577
2010-01-25T00:00:00Z